Glenmark Life Sciences Limited IPO

Glenmark Life Sciences Limited IPO Details, Financials, Subscription Status, GMP & More.

Glenmark Life Sciences Limited Logo
Glenmark Life Sciences Limited IPO Details & Company Portfolio / Business Model: Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.
You can even check more Glenmark Life Sciences Limited IPO’s latest news from this portal. Our aim is to keep you up to date on Upcoming IPO information.

Glenmark Life Sciences IPO Details

IPO Opening Date Jul 27, 2021
IPO Closing Date Jul 29, 2021
Type Of Issue Book Built Issue IPO
Current Face Value ₹2 per equity share
IPO Price ₹695 to ₹720 per equity share
Market Lot Size 20 Shares
Minimum Order Quantity 20 Shares
Will Be Listed At BSE, NSE
Issue Size [.] Eq Shares of ₹2
(aggregating up to ₹1,513.60 Cr)
Fresh Issue [.] Eq Shares of ₹2
(aggregating up to ₹1,060.00 Cr)
Offer for Sale 6,300,000 Eq Shares of ₹2
(aggregating up to ₹453.60 Cr)

Glenmark Life Sciences Limited IPO Prospectus

This information shows all information about Glenmark Life Sciences Limited IPO. You can check more detailed information like company registrar information of this IPO and more information about the promoter holdings from this page itself.

Company Financial Reports

Summary of financial Information (Restated Consolidated)

Year/Period (₹ in million)
31-Mar-21 31-Mar-20 31-Mar-19
Total Assets 19,970.75 17,256.04 14,753.95
Total Revenue 18,859.76 15,493.03 8,868.65
Profit After Tax 3,515.81 3,130.98 1,955.92

With the help of the above information, you can figure out company performance over the last few years. You can identify if the company is making profits or losses.

Glenmark Life Sciences IPO Timetable

The Glenmark Life Sciences IPO open date is Jul 27, 2021, and the close date is Jul 29, 2021. The issue may list on Aug 6, 2021.

IPO Open Date Jul 27, 2021
IPO Close Date Jul 29, 2021
Basis of Allotment Date Aug 3, 2021
Initiation of Refunds Aug 4, 2021
The credit of Shares to Demat Account Aug 5, 2021
IPO Listing Date Aug 6, 2021

This table is essential as it provides you the complete information about the upcoming IPO’s lot size, several shares, and the minimum amount required to apply for this IPO.

Glenmark Life Sciences IPO Lot Size

The Glenmark Life Sciences IPO market lot size is 20 shares. A retail-individual investor can apply for up to 13 lots (260 shares or ₹187,200).

Application Lots Shares Amount (Cut-off)
Minimum 1 20 ₹14,400
Maximum 13 260 ₹187,200

Company Promoters & Holding

Glenmark Pharmaceuticals Limited is the promoter of the company.

Company Promoters play a vital role in any company’s success. That’s you need a clear idea about who are the promoters behind this company. You can even check the names given below for a better idea.

Company Registrar & Address

Glenmark Life Sciences IPO Registrar:

KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]

You can also check the company contact information given below, with the help of this information you can communicate with the company easily.

Company Contact Information:

Glenmark Life Sciences Limited
Plot No. 170-172, Chandramouli Industrial Estate,
Mohol Bazarpeth, Solapur 413 213,

Phone: +91 2189 234456/ +91 2189
Email: [email protected]

This is the complete information about the Glenmark Life Sciences Limited IPO. If you have any queries/questions regarding any information provided above then feel free to contact us anytime or leave a comment below.

Glenmark Life Sciences Limited IPO Subscription Status (Final Data)

Category Day 1 Day 2 Day 3
QIB 0,00x 1.38x 36.97x
NII 0.85x 3.39x 122.54x
RII 5.16x 9.25x 14.63x
Total 2.78x 5.77x 44.17x

Glenmark Life Sciences Limited IPO Subscription Status will be updated in the table regularly. Keep visiting this page to get daily latest IPO subscription updates. If this table is not updated then you can request the updates by commenting below. (Updated Frequently)

GMP (Grey Market Premium)

We are here to provide you with detailed information about the current GMP OF IPO from this page itself. Just be with us and request updates about the IPO Grey Market Premium.

Leave a Comment